Health & Beauty

Pregnancy and Covid-19

Based on the available data, it is not yet known whether the intake of COVID-19 during pregnancy will cause long-term problems for the baby. Some have hinted at the possibility that the virus could be transmitted from a person who is pregnant to their baby, but researchers need more information to confirm this possibility. Although the virus can be transmitted to a baby during pregnancy, it seems to be very rare. (2)


If a woman has COVID-19 and plans to pump her breast milk, she should disinfect her hands before and after using the pump. Women who want to breastfeed should wear a face mask and disinfect their hands before touching the baby. This is possible regardless of whether or not Covid-19 is present during feeding. (4)

No cases of babies receiving COVID-19 from breast milk have been reported. Particles of the virus have been found in a small number of breast milk samples from women with Covid-19, but they are not expected to cause infection in babies. In fact, breast milk provides protection against many infections in childhood. As a result, the virus that causes the virus is unlikely to reach anyone else through breast milk. (2)

There is no evidence that COVID-19 infection in early pregnancy increases the likelihood of miscarriage. Current evidence suggests that if you have the virus, it is unlikely to cause any problems with the development of your babies, and there are no reports of it. (3)

Studies have shown that if a pregnant woman becomes unwell with COVID-19, she is at two to three times the risk of giving birth. However, in most cases, despite this increased risk, it is recommended that your baby be born prematurely in order to serve his or her health and allow him or her to recover. It is important to stress that in the majority of reported cases, newborns develop the virus before birth and remain so. (3)

For more than a year during the pandemic, research groups around the world have shown that pregnant women with COVID-19 have a higher risk of hospitalization for serious illnesses than women of the same age who are not pregnant. Rates of serious illness and death are higher for pregnant women from certain ethnic minorities than for non-minorities, reflecting the situation in the overall population. The good news is that babies who are spared severe respiratory infections don’t get sick. (5)

There are very few reports of serious cases in newborns. In most cases, newborns with COVID-19 showed mild symptoms and made a full recovery. There have been some cases of premature birth or other pregnancy or birth problems in women infected with the virus. Experts do not know if these problems are related to the virus itself. (4)

If you develop COVID-19 or any other disease and develop a fever, talk to your doctor as soon as possible about the best way to lower the fever. There is limited information about COid-19 and pregnancy. Research is limited, and the available studies reporting COID-19 infections during pregnancy do not show birth defects related to the virus. (2)

Although some studies have reported maternal mortality, there is limited information on SARS-CoV-2 infection in severely ill pregnant women who have been hospitalized with COVID-19 (8, 9). There are numerous case reports of infection with Sars-CoC-2 during pregnancy, but these cases have small sample sizes, making it difficult to find possible complications (10, 11). (7)

Maternal deaths due to cardiopulmonary complications and multiorgan failure have been reported in previous literature (9, 31, 102, 145). In one study, pregnant women with SARS-CoV-2 infection died of these complications in the second and third trimesters of pregnancy (9). (7)

Severe pregnancies and neonatal complications are higher in women with fever and shortness of breath, reflecting systemic diseases, and their presence for 1-4 days is associated with severe maternal and neonatal complications. These observations can influence clinical care and referral strategies. (0)

The risk of severe neonatal complications, including stays of 7 days or more, and the summary index of severe neonatal morbidity and its individual components were higher in this group of women diagnosed with COVID-19. The increased newborn risk remained even after taking into account previous preterm births and the preterm birth index during pregnancy, so a direct effect on newborns with COid-19 is likely. (0)

Our results show that COVID-19 is usually diagnosed in the third trimester. However, most women avoid the hospital during late pregnancy and labor. Women diagnosed with Covid-19 early in pregnancy or at the end of pregnancy were under-represented in our hospital study due to previous infections that manifested as mild symptoms that were ignored or poorly treated in primary care. (0)

To investigate the impact of Coronavirus Disease 2019 (COVID-19) on mortality in pregnant women and childbirth, we conducted a systematic review of the available published literature on how pregnancy is affected by Covid-19. The Web of Science, Scopus and Medline databases were searched for original studies on the effects of the virus on pregnancy. A meta-analysis of the proportions was used to combine the data reported in the pooled proportions. (7)

Of 138 pregnant patients from across the country, 81 were recruited on the basis of eligibility criteria and informed consent, including 65 births (80.2%) and 16 abortions (19.8%). Inclusion criteria included follow-up of confirmed cases of COVID-19 (defined as suspected cases with positive results from high-throughput sequencing of the real-time reverse transcriptase polymerase chain reaction (RT-PCR) nasal and pharyngeal swabs) of pregnant women diagnosed with Covid-19 at the onset of the virus during pregnancy, with informed consent of pregnant women. Pregnant women were invited to take part in follow-up examinations up to three months after childbirth or abortion. Exclusion criteria are follow-up care after the onset of HIV / CoV-19 or after the loss of pregnancy to follow-up care. As of July 31, 2020, we tracked 57 births and 15 abortions (Fig. (1)

The findings appear on October 7 in Obstetrics and Gynecology. The Priority Study of Pregnancy Coronavirus Outcomes Registry is an ongoing study in the United States of women who are pregnant or in the sixth week of pregnancy with confirmed or suspected cases of COVID-19. Previous research on SARS-CoV-2 infection during pregnancy has focused on inpatient patients, but this study focuses on outpatient patients who make up the overwhelming majority of adult SARS / CoV / 2 infections during pregnancy. (6)

One of the biggest unknowns of the pandemic is how SARS-CoV-2 is transmitted from mother to baby. For most premature births in women with COVID-19 that occur in the last three months of pregnancy, the fetus has the best chance of healthy development. Premature births can lead to health problems later in life. However, the virus has not been associated with a significant increase in stillbirths or halted fetal growth. (5)

Pregnant women have an immune system that is considered more normal than that of pregnant women with other forms of infection or underlying diseases. There is no evidence that women who have already had a baby and are doing well have an increased risk of developing COVID-19 or becoming ill. (3)